David Davidson, Chief Medical Officer at bluebird bio, Inc. (BLUE), sold 9,482 shares at $155.85 ($1.5M) on 2019-03-04, disclosed to the SEC on 2019-03-06.
Seasonal sale ($1.5M) by Chief Medical Officer — this insider has traded BLUE in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.07 | 1,947 | $302K | 20.4% |
| 2 | $155.07 | 1,947 | $302K | 20.4% |
| 3 | $155.85 | 2,225 | $347K | 23.5% |
| 4 | $155.85 | 2,225 | $347K | 23.5% |
| 5 | $157.00 | 338 | $53K | 3.6% |
| 6 | $157.70 | 400 |
| $63K |
| 4.3% |
| 7 | $157.70 | 400 | $63K | 4.3% |
| Total | $155.73 avg | 9,482 | $1.5M | 100% |
| Filing → |
| BLUE | SELL | 2021-02-18 | $20K | — | Filing → |
| BLUE | SELL | 2021-02-04 | $3K | — | Filing → |
| BLUE | SELL | 2021-01-08 | $288K | — | Filing → |